These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33162751)

  • 1. Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments.
    Stalmans I; Lemij H; Clarke J; Baudouin C;
    Clin Ophthalmol; 2020; 14():3675-3680. PubMed ID: 33162751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient satisfaction with glaucoma therapy: reality or myth?
    Lemij HG; Hoevenaars JG; van der Windt C; Baudouin C
    Clin Ophthalmol; 2015; 9():785-93. PubMed ID: 25999687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular surface disease and glaucoma: how to evaluate impact on quality of life.
    Rossi GC; Pasinetti GM; Scudeller L; Bianchi PE
    J Ocul Pharmacol Ther; 2013 May; 29(4):390-4. PubMed ID: 23215770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of ocular surface disease in glaucoma patients.
    Leung EW; Medeiros FA; Weinreb RN
    J Glaucoma; 2008 Aug; 17(5):350-5. PubMed ID: 18703943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors to develop ocular surface disease 
in treated glaucoma or ocular hypertension patients.
    Rossi GC; Pasinetti GM; Scudeller L; Raimondi M; Lanteri S; Bianchi PE
    Eur J Ophthalmol; 2013; 23(3):296-302. PubMed ID: 23335308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication.
    Ghosh S; O'Hare F; Lamoureux E; Vajpayee RB; Crowston JG
    Clin Exp Ophthalmol; 2012; 40(7):675-81. PubMed ID: 22394358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy.
    Ruiz-Lozano RE; Azar NS; Mousa HM; Quiroga-Garza ME; Komai S; Wheelock-Gutierrez L; Cartes C; Perez VL
    Front Toxicol; 2023; 5():1067942. PubMed ID: 37547228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular surface disease incidence in patients with open-angle glaucoma.
    Radenković M; Stanković-Babić G; Jovanović P; Djordjević-Jocić J; Trenkić-Božinović M
    Srp Arh Celok Lek; 2016; 144(7-8):376-83. PubMed ID: 29652117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis.
    Portela RC; Fares NT; Machado LF; São Leão AF; de Freitas D; Paranhos A; Prata TS; Gracitelli CPB
    J Glaucoma; 2018 Sep; 27(9):794-801. PubMed ID: 29916999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the clinical measurement of ocular surface disease in glaucoma patients.
    Pflugfelder SC; Baudouin C
    Clin Ophthalmol; 2011; 5():1575-83. PubMed ID: 22125404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
    Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
    Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
    Mlčáková E; Mlčák P; Karhanová M; Langová K; Marešová K
    Cesk Slov Oftalmol; 2016; 72(4):120-127. PubMed ID: 27860477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy].
    Gomes B; Turiel PR; Marques FP; Bernardo FP; Safady MV; Portes AL; Santhiago MR
    Arq Bras Oftalmol; 2013 Oct; 76(5):282-7. PubMed ID: 24232941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand.
    Ruangvaravate N; Prabhasawat P; Vachirasakchai V; Tantimala R
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):387-394. PubMed ID: 29596033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma.
    Pérez-Bartolomé F; Martínez-de-la-Casa JM; Arriola-Villalobos P; Fernández-Pérez C; Polo V; García-Feijoó J
    Eur J Ophthalmol; 2017 Nov; 27(6):694-704. PubMed ID: 28497458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear film osmolarity in patients treated for glaucoma or ocular hypertension.
    Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
    Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.
    Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
    Curr Med Res Opin; 2010 Aug; 26(8):1905-13. PubMed ID: 20553122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.